NCT00584363

Brief Summary

The purpose of the study is to collect pancreatic tissue, blood and urine from adults to study pancreatic abnormalities.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
731

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2004

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2004

Completed
3.6 years until next milestone

First Submitted

Initial submission to the registry

December 24, 2007

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 2, 2008

Completed
9.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2017

Completed
Last Updated

October 5, 2017

Status Verified

October 1, 2017

Enrollment Period

13.3 years

First QC Date

December 24, 2007

Last Update Submit

October 4, 2017

Conditions

Pancreatic Cancer

Outcome Measures

Primary Outcomes (1)

  • To diagnose Pancreatic Cancer

    5 years

Secondary Outcomes (1)

  • Preventing patient form being misdiagnosed

    5 years

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults 19 years of age or older, pancreatic cancer patients at the University of Alabam at Birmingham.

You may qualify if:

  • Person over 19 years of age, patient with a tissue-proven diagnosis of pancreatic cancer at the University of Alabama at Birmingham (UAB) University Hospital during the period, and cognitive ability to provide informed consent

You may not qualify if:

  • Person not 19 or older and have not had a tissue-proven diagnosis of pancreatic cancer.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alabama at Birmingham

Birmingham, Alabama, 35294, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

Specimens are frozen and stored

MeSH Terms

Conditions

Pancreatic Neoplasms

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteNeoplasmsEndocrine Gland NeoplasmsDigestive System DiseasesPancreatic DiseasesEndocrine System Diseases

Study Officials

  • Charles M Wilcox, MD

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 24, 2007

First Posted

January 2, 2008

Study Start

June 1, 2004

Primary Completion

September 1, 2017

Study Completion

September 1, 2017

Last Updated

October 5, 2017

Record last verified: 2017-10

Locations

US(1)